Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 1 Interventional

A Phase I Trial to Evaluate Didanosine (ddI) in HIV-Infected Pregnant Women

ClinicalTrials.gov ID: NCT00000839

Open the official record

This page only displays public information reproduced from the official ClinicalTrials.gov record NCT00000839. It adds no medical advice, opinions, or eligibility judgments. The official record remains the source of truth for eligibility criteria, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Nov 17, 2026, 5:33 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

To assess the pharmacokinetics, safety, and toxicity of intravenous and oral didanosine (ddI) administration in third trimester pregnant women who are HIV positive but are either intolerant or resistant to zidovudine (AZT). To collect data on infant toxicity following maternal treatment with ddI during the third trimester of pregnancy. AZT may not be the optimal antiretroviral agent for all pregnant women requiring therapy for HIV infection. Although ddI has been approved for use in HIV-infected adults and older children, the safety and pharmacokinetics of ddI in pregnant women has not yet been determined.

Study identification

NCT ID
NCT00000839
Recruitment status
Completed
Study type
Interventional
Phase
Phase 1
Enrollment
12 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
13 Years and older
Sex
Female
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Not listed
Primary completion
Not listed
Completion
Jun 2001 (Actual)
Last update posted
Oct 29, 2021

Ends 2001

United States locations

U.S. sites
11
U.S. states
7
U.S. cities
9
Facility City State ZIP Site status
UCLA-Los Angeles/Brazil AIDS Consortium (LABAC) CRS Los Angeles California 90095 —
UCSD Maternal, Child, and Adolescent HIV CRS San Diego California 92093 —
Univ. of Florida Jacksonville NICHD CRS Jacksonville Florida 32209 —
Univ. of Miami Ped. Perinatal HIV/AIDS CRS Miami Florida 33161 —
Rush Univ. Med. Ctr. ACTG CRS Chicago Illinois 60612 —
Tulane Univ. Health Science Ctr., Tulane Univ. Hosp. & Clinic New Orleans Louisiana 70112 —
Tulane/LSU Maternal/Child CRS New Orleans Louisiana 70112 —
NJ Med. School CRS Newark New Jersey 07103 —
Columbia IMPAACT CRS New York New York 10032 —
Incarnation Children's Ctr. New York New York 10032 —
DUMC Ped. CRS Durham North Carolina 27710 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 2 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00000839, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Oct 29, 2021 · Synced Nov 17, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.